You Are Here: Home > About Arthritis > Arthritis in the News > Alberta will force patients to switch from biologics to cheaper biosimilar medications

Alberta will force patients to switch from biologics to cheaper biosimilar medications

Globe and Mail coverage of the Alberta biosimilars announcement, highlighting some (non-arthritis) patient groups' concerns.Back to News